Sign in
4

Changes in Ownership

Mineralys Therapeutics, Inc. Filed Acc 0001933414-25-000078

Chief Executive Officer sold 15,884 shares at $14.51 ($230,431)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Congleton Jon Chief Executive Officer 2025-07-11 Sale 10b5-1 −15,884 $14.51 $230,431 846,405 D
Open-market sales · 15,884 sh · avg $14.51 · $230,431
Loading xslF345X05/wk-form4_1752613354.xml…